DermR Health is a dermatology-focused biotech company developing a novel microsampling device and genetic testing platform to transform skin cancer detection, diagnosis, treatment pathways and beyond. 

Our mission is to replace 1 billion skin biopsies by addressing the growing global challenges of inefficient skin cancer diagnosis, where over 60% of biopsies and excisions are benign and could be avoided. 

We’re enabling earlier, more accessible, and less invasive testing solutions, to advance global health equity.

DermR Health

Org chart

Teams

Offices